Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CYBR
276
DELISTED
CyberArk
CYBR
| $287M | 0.05% |
861,061
+245,539
| +40% | +$74.6M |
|
277
CALL
Robinhood
HOOD
$84.9B
| $286M | 0.05% |
7,683,000
+1,605,500
| +26% | +$51.8M |
|
278
CVS Health
CVS
$120B
| $286M | 0.05% |
6,366,445
+4,202,234
| +194% | +$236M |
|
279
PUT
GE Aerospace
GE
$382B
| $285M | 0.05% |
1,708,200
-531,200
| -24% | -$94.8M |
|
280
PUT
Chevron
CVX
$386B
| $282M | 0.05% |
1,946,900
-60,200
| -3% | -$9.21M |
|
281
United Airlines
UAL
$41B
| $278M | 0.05% |
2,866,977
-1,025,263
| -26% | -$86.7M |
|
282
Microchip Technology
MCHP
$44B
| $278M | 0.05% |
4,844,664
+4,661,441
| +2,544% | +$320M |
|
283
AstraZeneca
AZN
$246B
| $277M | 0.05% |
2,111,409
+1,887,183
| +842% | +$264M |
|
284
Applovin
APP
$107B
| $276M | 0.05% |
852,126
+783,039
| +1,133% | +$198M |
|
285
PUT
Carvana
CVNA
$79.2B
| $275M | 0.05% |
6,756,500
-506,000
| -7% | -$22.7M |
|
286
CALL
Accenture
ACN
$110B
| $274M | 0.05% |
779,900
+42,900
| +6% | +$15.4M |
|
287
CALL
Western Digital
WDC
$151B
| $273M | 0.05% |
6,067,675
+1,347,476
| +29% | +$67.7M |
|
288
DoorDash
DASH
$91.9B
| $273M | 0.05% |
1,630,000
-627,872
| -28% | -$103M |
|
289
PUT
Bristol-Myers Squibb
BMY
$130B
| $273M | 0.05% |
4,827,400
-2,312,500
| -32% | -$129M |
|
290
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| $272M | 0.05% |
3,020,800
+745,100
| +33% | +$72.2M |
|
291
Marvell Technology
MRVL
$191B
| $271M | 0.05% |
2,453,328
+1,186,676
| +94% | +$110M |
|
292
CALL
ProShares UltraPro QQQ
TQQQ
$36.7B
| $270M | 0.05% |
6,819,600
-4,273,000
| -39% | -$168M |
|
293
Johnson & Johnson
JNJ
$626B
| $270M | 0.05% |
1,865,202
+1,207,406
| +184% | +$187M |
|
294
Marriott International
MAR
$91.1B
| $269M | 0.05% |
963,810
-791,119
| -45% | -$217M |
|
295
CALL
ARK Innovation ETF
ARKK
$6.38B
| $269M | 0.05% |
4,731,300
+652,000
| +16% | +$34.9M |
|
296
CALL
State Street Industrial Select Sector SPDR ETF
XLI
$34.7B
| $268M | 0.05% |
2,033,600
+334,300
| +20% | +$46.1M |
|
297
CALL
Applied Materials
AMAT
$417B
| $268M | 0.05% |
1,645,400
-92,500
| -5% | -$16.8M |
|
298
PUT
GE Vernova
GEV
$269B
| $267M | 0.05% |
811,700
+350
| +0% | +$109K |
|
299
PUT
iShares Bitcoin Trust
IBIT
$47.2B
| $266M | 0.05% |
+5,019,700
| New | +$237M |
|
300
CALL
Vertiv
VRT
$108B
| $266M | 0.05% |
2,342,300
+667,800
| +40% | +$79.3M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.